MCID: CTN010
MIFTS: 28

Cutaneous Ganglioneuroma

Categories: Cancer diseases, Skin diseases

Aliases & Classifications for Cutaneous Ganglioneuroma

MalaCards integrated aliases for Cutaneous Ganglioneuroma:

Name: Cutaneous Ganglioneuroma 12 15
Ganglioneuroma of Skin 12 71

Classifications:



External Ids:

Disease Ontology 12 DOID:2425
NCIt 49 C4481
SNOMED-CT 67 254766004
UMLS 71 C0346063

Summaries for Cutaneous Ganglioneuroma

MalaCards based summary : Cutaneous Ganglioneuroma, also known as ganglioneuroma of skin, is related to gangliocytoma and ganglioneuroma. An important gene associated with Cutaneous Ganglioneuroma is CNP (2',3'-Cyclic Nucleotide 3' Phosphodiesterase), and among its related pathways/superpathways are Hematopoietic Stem Cells and Lineage-specific Markers and Neuroscience. Affiliated tissues include skin and adipocyte, and related phenotypes are cellular and nervous system

Related Diseases for Cutaneous Ganglioneuroma

Diseases related to Cutaneous Ganglioneuroma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 306, show less)
# Related Disease Score Top Affiliating Genes
1 gangliocytoma 30.9 SYP ENO2
2 ganglioneuroma 30.2 SYP NCAM1 ENO2 CHGA
3 neurofibroma 28.6 SYP MITF KIT CNP CD34
4 neuroblastoma 28.1 SYP NCAM1 KIT ENO2 CHGA APP
5 vulvar apocrine adenocarcinoma 10.3 KRT20 ENO2
6 vaginal glandular tumor 10.3 ENO2 CHGA
7 gastric gastrinoma 10.3 ENO2 CHGA
8 middle cerebral artery infarction 10.3 NCAM1 ENO2
9 nodular ganglioneuroblastoma 10.3 ENO2 CHGA
10 ewing sarcoma of bone 10.3 ENO2 CHGA
11 appendix lymphoma 10.3 ENO2 CHGA
12 malignant melanocytic neoplasm of the peripheral nerve sheath 10.3 SYP ENO2
13 eyelid benign neoplasm 10.3 KRT20 CHGA
14 bile duct adenoma 10.3 NCAM1 KRT20
15 penis sarcoma 10.3 ENO2 CD34
16 sinonasal undifferentiated carcinoma 10.3 SYP ENO2
17 angiomyoma 10.3 ENO2 CD34
18 cerebral neuroblastoma 10.3 SYP ENO2
19 papillary tumor of the pineal region 10.3 SYP ENO2
20 intracranial primitive neuroectodermal tumor 10.3 SYP ENO2
21 female urethral cancer 10.2 KRT20 CHGA
22 bile duct mucinous adenocarcinoma 10.2 SYP ENO2
23 extraosseous ewings sarcoma-primitive neuroepithelial tumor 10.2 SYP ENO2
24 nodular prostate 10.2 SYP ENO2
25 pacinian tumor 10.2 ENO2 CD34
26 cerebellar liponeurocytoma 10.2 SYP ENO2
27 solid adenocarcinoma with mucin production 10.2 NCAM1 CHGA
28 lung combined type small cell carcinoma 10.2 SYP NCAM1
29 papillary ependymoma 10.2 SYP ENO2
30 nasal cavity benign neoplasm 10.2 NCAM1 CD34
31 frontal lobe neoplasm 10.2 SYP ENO2
32 hypoganglionosis 10.2 SYP NCAM1
33 myoblastoma 10.2 SYP ENO2
34 malignant granular cell myoblastoma 10.2 ENO2 CD34
35 pineal parenchymal tumor of intermediate differentiation 10.2 SYP ENO2
36 optic nerve astrocytoma 10.2 SYP ENO2
37 adrenal neuroblastoma 10.2 SYP ENO2
38 pulmonary artery leiomyosarcoma 10.2 ENO2 CD34
39 extraskeletal ewing sarcoma 10.2 SYP ENO2
40 congenital granular cell tumor 10.2 ENO2 CD34
41 spinal cord oligodendroglioma 10.2 SYP ENO2
42 vulvar leiomyoma 10.2 NCAM1 CD34
43 krukenberg carcinoma 10.2 SYP KRT20
44 clear cell ependymoma 10.2 SYP ENO2
45 keratosis 10.2
46 keratosis, seborrheic 10.2
47 inverted follicular keratosis 10.2
48 rhabdoid meningioma 10.2 SYP ENO2
49 colonic lymphangioma 10.2 KRT20 CD34
50 cerebrovascular benign neoplasm 10.2 SYP ENO2
51 extraosseous ewing sarcoma 10.2 SYP ENO2
52 cerebellum cancer 10.2 SYP ENO2
53 endobronchial lipoma 10.2 SYP ENO2
54 cerebellar medulloblastoma 10.2 SYP ENO2
55 central nervous system primitive neuroectodermal neoplasm 10.2 SYP ENO2
56 clear cell basal cell carcinoma 10.2 KRT20 CHGA
57 pineal gland cancer 10.2 SYP ENO2
58 ependymoblastoma 10.2 SYP ENO2
59 thyroid angiosarcoma 10.2 KRT20 CD34
60 primary hepatic neuroendocrine carcinoma 10.2 SYP CHGA
61 extraosseous chondrosarcoma 10.2 SYP ENO2
62 acinar cell cystadenocarcinoma 10.2 SYP CHGA
63 glomangioma 10.2 SYP CD34
64 vulvar eccrine porocarcinoma 10.2 SYP CHGA
65 cervical large cell neuroendocrine carcinoma 10.1 SYP CHGA
66 gastrointestinal neuroendocrine benign tumor 10.1 SYP CHGA
67 adenoid squamous cell carcinoma 10.1 KRT20 CD34
68 mixed ductal-endocrine carcinoma 10.1 SYP CHGA
69 scleredema adultorum 10.1 NCAM1 CD34
70 breast papillary carcinoma 10.1 SYP CHGA
71 ovarian small cell carcinoma 10.1 SYP ENO2
72 melanotic neuroectodermal tumor 10.1 SYP ENO2
73 gastric neuroendocrine neoplasm 10.1 SYP CHGA
74 subleukemic leukemia 10.1 SYP ENO2
75 askin's tumor 10.1 SYP ENO2
76 pancreatic gastrinoma 10.1 SYP CHGA
77 gastrointestinal neuroendocrine tumor 10.1 SYP CHGA
78 sclerosing hepatic carcinoma 10.1 CHGA CD34
79 glomangiomyoma 10.1 SYP CD34
80 lung meningioma 10.1 SYP CD34
81 pancreatic acinar cell adenocarcinoma 10.1 SYP CHGA
82 spinal cancer 10.1 SYP ENO2
83 extra-adrenal pheochromocytoma 10.1 SYP CHGA
84 epithelioid malignant peripheral nerve sheath tumor 10.1 CHGA CD34
85 neurofibrosarcoma 10.1 ENO2 CD34
86 ureter transitional cell carcinoma 10.1 NCAM1 ENO2 CHGA
87 astroblastoma 10.1 SYP ENO2
88 supratentorial primitive neuroectodermal tumor 10.1 SYP NCAM1
89 lymphoepithelioma-like carcinoma 10.1 KRT20 ENO2
90 bone benign neoplasm 10.1 SYP ENO2
91 goblet cell carcinoid 10.1 KRT20 ENO2 CHGA
92 myxopapillary ependymoma 10.1 SYP NCAM1
93 ganglioneuroblastoma 10.1 SYP GNS ENO2
94 rare tumor 10.0
95 anal neuroendocrine tumor 10.0 SYP NCAM1 ENO2
96 adult xanthogranuloma 10.0 MITF CD34
97 cerebellopontine angle primitive neuroectodermal tumor 10.0 SYP NCAM1 ENO2
98 cerebrum cancer 10.0 SYP ENO2
99 nasal cavity olfactory neuroblastoma 10.0 SYP NCAM1 ENO2
100 subungual glomus tumor 10.0 SYP CD34
101 adrenal medulla cancer 10.0 SYP CHGA
102 cerebral ventricle cancer 10.0 SYP ENO2
103 bladder lateral wall cancer 10.0 SYP KRT20 ENO2
104 obstructive hydrocephalus 10.0 SYP ENO2
105 cystic basal cell carcinoma 10.0 SYP KRT20 ENO2
106 medulloepithelioma 10.0 SYP KRT20 ENO2
107 skin benign neoplasm 10.0 KRT20 ENO2 CD34
108 intratubular embryonal carcinoma 10.0 KRT20 KIT
109 breast neuroendocrine neoplasm 9.9 SYP ENO2 CHGA
110 appendix carcinoid tumor 9.9 SYP ENO2 CHGA
111 auditory system cancer 9.9 SYP ENO2 CHGA
112 cauda equina neoplasm 9.9 SYP ENO2 CHGA
113 duodenal benign neoplasm 9.9 SYP ENO2 CHGA
114 ampulla of vater neoplasm 9.9 SYP ENO2 CHGA
115 middle ear adenoma 9.9 SYP ENO2 CHGA
116 carotid body cancer 9.9 SYP ENO2 CHGA
117 pineocytoma 9.9 SYP ENO2 CHGA
118 lung oat cell carcinoma 9.9 SYP ENO2 CHGA
119 cervix small cell carcinoma 9.9 SYP ENO2 CHGA
120 carcinoid tumors, intestinal 9.9 SYP ENO2 CHGA
121 thymus clear cell carcinoma 9.9 KRT20 KIT
122 carcinoid syndrome 9.9 SYP ENO2 CHGA
123 olfactory neuroblastoma 9.9 SYP ENO2 CHGA
124 granulosa cell tumor of the ovary 9.9 SYP ENO2 CHGA
125 pancreatoblastoma 9.9 SYP CHGA
126 microcystic adenoma 9.9 SYP ENO2 CHGA
127 pulmonary sclerosing hemangioma 9.9 SYP ENO2 CHGA
128 esophageal neuroendocrine tumor 9.9 SYP NCAM1 CHGA
129 sclerosing hemangioma 9.9 SYP ENO2 CHGA
130 papillary thymic adenocarcinoma 9.9 SYP NCAM1 CHGA
131 laryngeal neuroendocrine tumor 9.9 SYP NCAM1 CHGA
132 central neurocytoma 9.9 SYP ENO2 CHGA
133 esophageal adenoid cystic carcinoma 9.9 SYP NCAM1 CHGA
134 adrenal cortical adenoma 9.9 SYP ENO2 CHGA
135 islet cell tumor 9.9 SYP ENO2 CHGA
136 pulmonary large cell neuroendocrine carcinoma 9.9 SYP NCAM1 CHGA
137 chordoid meningioma 9.9 SYP NCAM1 CHGA
138 pancreatic endocrine carcinoma 9.9 SYP NCAM1 CHGA
139 ganglioglioma 9.9 SYP ENO2 CHGA
140 lung large cell carcinoma 9.9 SYP NCAM1 CHGA
141 vaginal tubulovillous adenoma 9.9 SYP KRT20 CHGA
142 primary pigmented nodular adrenocortical disease 9.9 SYP NCAM1 CHGA
143 endocrine organ benign neoplasm 9.9 SYP ENO2 CHGA
144 appendix adenocarcinoma 9.9 SYP KRT20 CHGA
145 vaginal adenoma 9.9 SYP KRT20 CHGA
146 vaginal benign neoplasm 9.9 SYP KRT20 CHGA
147 supratentorial cancer 9.9 SYP ENO2
148 adrenal carcinoma 9.9 SYP ENO2 CHGA
149 peritoneal serous adenocarcinoma 9.9 SYP KRT20 CHGA
150 microphthalmia 9.9
151 nevus, epidermal 9.9
152 neurofibromatosis 9.9
153 spinal cord sarcoma 9.9 KIT CD34
154 gallbladder leiomyoma 9.9 KIT CD34
155 dowling-degos disease 1 9.9 MITF KIT
156 small intestine leiomyosarcoma 9.9 KIT CD34
157 glomangiosarcoma 9.9 SYP NCAM1 CD34
158 myxoid chondrosarcoma 9.9 SYP CHGA
159 deep leiomyoma 9.9 KIT CD34
160 glomus tumor 9.9 SYP ENO2 CD34
161 exophthalmos 9.9 SYP ENO2 CD34
162 mucocele of appendix 9.9 KIT CD34
163 chondrosarcoma, extraskeletal myxoid 9.9 SYP ENO2 CD34
164 gastric liposarcoma 9.9 KIT CD34
165 gallbladder leiomyosarcoma 9.9 KIT CD34
166 liver leiomyoma 9.9 KIT CD34
167 hemangioblastoma 9.9 SYP ENO2 CD34
168 papillary carcinoma 9.9 SYP KRT20 CHGA
169 colon leiomyosarcoma 9.9 KIT CD34
170 hypomelanosis of ito 9.8 MITF KIT
171 benign fibrous mesothelioma 9.8 KIT CD34
172 small intestine leiomyoma 9.8 KIT CD34
173 papilloma of choroid plexus 9.8 SYP ENO2
174 retroperitoneal leiomyosarcoma 9.8 KIT CD34
175 heart sarcoma 9.8 KIT CD34
176 central epithelioid sarcoma 9.8 SYP KRT20 CD34
177 vulvar proximal-type epithelioid sarcoma 9.8 SYP KRT20 CD34
178 hepatic angiomyolipoma 9.8 KIT CD34
179 breast malignant phyllodes tumor 9.8 KIT CD34
180 sarcomatous intrahepatic cholangiocarcinoma 9.8 KIT CD34
181 retroperitoneal sarcoma 9.8 KIT CD34
182 gliosarcoma 9.8 SYP ENO2 CD34
183 vaginal endometrial stromal sarcoma 9.8 KIT CD34
184 esophagus sarcoma 9.8 KIT CD34
185 clear cell meningioma 9.8 SYP CHGA CD34
186 tuberous sclerosis 9.8 SYP ENO2 CHGA
187 tenosynovial giant cell tumor 9.8 KIT CD34
188 vagina sarcoma 9.8 KIT CD34
189 nodular malignant melanoma 9.8 MITF KIT
190 ovarian germ cell cancer 9.8 SYP KIT
191 dysgerminoma 9.8 KRT20 KIT ENO2
192 waardenburg syndrome, type 4b 9.8 MITF KIT
193 heart cancer 9.7 KIT CD34
194 autonomic nervous system neoplasm 9.7 SYP ENO2 APP
195 autonomic nervous system benign neoplasm 9.7 SYP GNS ENO2 CHGA
196 peripheral nervous system benign neoplasm 9.7 SYP GNS ENO2 CHGA
197 oligodendroglioma 9.7 SYP ENO2 CNP CHGA
198 binswanger's disease 9.7 SYP CHGA APP
199 auditory system benign neoplasm 9.7 SYP NCAM1 ENO2 CHGA
200 ureter small cell carcinoma 9.7 SYP NCAM1 ENO2 CHGA
201 gallbladder small cell carcinoma 9.7 SYP NCAM1 ENO2 CHGA
202 gastric small cell carcinoma 9.7 SYP NCAM1 ENO2 CHGA
203 sensory organ benign neoplasm 9.7 SYP NCAM1 ENO2 CHGA
204 subependymoma 9.7 SYP NCAM1 ENO2 CHGA
205 cervical neuroblastoma 9.7 SYP NCAM1 ENO2 CHGA
206 colon neuroendocrine neoplasm 9.7 SYP NCAM1 ENO2 CHGA
207 extracranial neuroblastoma 9.7 SYP NCAM1 ENO2 CHGA
208 pulmonary neuroendocrine tumor 9.7 SYP NCAM1 ENO2 CHGA
209 olfactory nerve neoplasm 9.7 SYP NCAM1 ENO2 CHGA
210 cranial nerve malignant neoplasm 9.7 SYP NCAM1 ENO2 CHGA
211 cranial nerve neoplasm 9.7 SYP NCAM1 ENO2 CHGA
212 subependymal giant cell astrocytoma 9.7 SYP NCAM1 ENO2 CHGA
213 malignant pheochromocytoma 9.7 SYP NCAM1 ENO2 CHGA
214 neuroma 9.7 KIT ENO2 CD34
215 perineurioma 9.7 NCAM1 KIT
216 small cell carcinoma of the bladder 9.7 SYP KRT20 ENO2 CHGA
217 pineal region teratoma 9.7 SYP KIT ENO2
218 horseshoe kidney 9.7 SYP KRT20 ENO2 CHGA
219 basaloid squamous cell carcinoma 9.7 SYP KRT20 ENO2 CHGA
220 cecal disease 9.7 SYP CHGA
221 plexiform schwannoma 9.7 KIT ENO2 CD34
222 benign teratoma 9.7 SYP KRT20 ENO2 CHGA
223 retroperitoneal hemangiopericytoma 9.7 KIT ENO2 CD34
224 breast leiomyosarcoma 9.7 KIT ENO2 CD34
225 pancreatic serous cystadenocarcinoma 9.7 SYP NCAM1 KRT20 CHGA
226 uterus leiomyosarcoma 9.7 SYP KIT ENO2
227 conventional fibrosarcoma 9.7 KIT ENO2 CD34
228 mature teratoma 9.7 SYP KIT ENO2
229 orbital cancer 9.6 SYP NCAM1 ENO2 CD34
230 connective tissue benign neoplasm 9.6 KIT ENO2 CD34
231 pick disease of brain 9.6 SYP CHGA APP
232 myeloid sarcoma 9.6 NCAM1 KIT CD34
233 inflammatory myofibroblastic tumor 9.6 KIT ENO2 CD34
234 dermatofibrosarcoma protuberans 9.6 KIT ENO2 CD34
235 vulvar disease 9.6 KRT20 KIT CD34
236 colorectal adenocarcinoma 9.6 KRT20 KIT CHGA
237 intestinal obstruction 9.6 KRT20 KIT CD34
238 chromophobe renal cell carcinoma 9.6 KRT20 KIT CHGA
239 malignant spindle cell melanoma 9.6 MITF KIT CD34
240 leukocyte disease 9.6 NCAM1 KIT CD34
241 oncocytoma 9.6 SYP KRT20 KIT
242 perivascular epithelioid cell tumor 9.6 SYP MITF KIT
243 bone marrow cancer 9.6 NCAM1 KIT CD34
244 respiratory system benign neoplasm 9.6 SYP ENO2 CHGA CD34
245 meckel diverticulum 9.6 KIT CHGA CD34
246 spindle cell carcinoma 9.5 SYP ENO2 CHGA CD34
247 cardiovascular organ benign neoplasm 9.5 SYP ENO2 CHGA CD34
248 adenosquamous carcinoma 9.5 SYP KIT CHGA
249 benign perivascular tumor 9.5 SYP KIT CD34
250 pancytopenia 9.5 NCAM1 KIT CD34
251 thymoma 9.5 SYP KIT ENO2
252 combined t cell and b cell immunodeficiency 9.5 NCAM1 KIT CD34
253 malignant teratoma 9.4 SYP S100A6 KIT ENO2
254 urinary bladder small cell neuroendocrine carcinoma 9.4 SYP NCAM1 KRT20 ENO2 CHGA
255 ovarian large-cell neuroendocrine carcinoma 9.4 SYP NCAM1 KRT20 ENO2 CHGA
256 prostate neuroendocrine neoplasm 9.4 SYP NCAM1 KRT20 ENO2 CHGA
257 tubular adenocarcinoma 9.4 SYP NCAM1 KRT20 ENO2 CHGA
258 lung benign neoplasm 9.4 SYP NCAM1 KRT20 ENO2 CHGA
259 neuroendocrine tumor 9.4 SYP NCAM1 KRT20 ENO2 CHGA
260 cystic teratoma 9.4 SYP KRT20 KIT ENO2
261 thymic carcinoma 9.4 SYP KRT20 KIT ENO2
262 clear cell sarcoma 9.4 SYP MITF KIT ENO2
263 malignant peripheral nerve sheath tumor 9.4 S100A6 MITF KIT CD34
264 fibrous histiocytoma 9.4 MITF KIT ENO2 CD34
265 neurilemmoma 9.4 MITF KIT ENO2 CD34
266 central nervous system benign neoplasm 9.3 SYP GNS ENO2 CHGA CD34
267 liver leiomyosarcoma 9.3 KIT ENO2 CHGA CD34
268 small intestine benign neoplasm 9.3 SYP KIT ENO2 CHGA
269 lentigines 9.3 MITF KIT
270 laryngeal small cell carcinoma 9.3 SYP NCAM1 KIT CHGA
271 muscle cancer 9.3 SYP KIT ENO2 CD34
272 endobronchial leiomyoma 9.3 SYP KIT ENO2 CD34
273 cystadenoma 9.3 SYP KRT20 KIT CHGA
274 hemangiopericytoma, malignant 9.3 SYP KIT ENO2 CD34
275 prostate stromal sarcoma 9.3 SYP NCAM1 KIT CD34
276 retroperitoneum carcinoma 9.2 SYP KRT20 KIT CD34
277 cavernous hemangioma 9.2 SYP KRT20 KIT CD34
278 cardiovascular cancer 9.2 SYP MITF KIT CD34
279 vascular cancer 9.2 SYP MITF KIT CD34
280 cell type benign neoplasm 9.2 SYP KIT CHGA CD34
281 hirschsprung disease 1 9.1 SYP NCAM1 MITF KIT ENO2
282 gastric hemangioma 9.1 SYP NCAM1 KIT ENO2 CHGA
283 endometrial small cell carcinoma 9.1 SYP NCAM1 KIT ENO2 CHGA
284 paraganglioma 9.1 SYP NCAM1 KIT ENO2 CHGA
285 suppression of tumorigenicity 12 9.1 SYP NCAM1 KIT ENO2 CHGA
286 teratoma 9.1 SYP KRT20 KIT ENO2 CHGA
287 thyroid gland cancer 9.0 SYP KRT20 KIT ENO2 CHGA
288 skeletal muscle cancer 9.0 SYP NCAM1 KIT ENO2 CD34
289 jejunal neoplasm 9.0 SYP KRT20 KIT ENO2 CD34
290 wilms tumor 1 9.0 SYP NCAM1 KIT ENO2 CD34
291 basal cell carcinoma 9.0 SYP NCAM1 KRT20 KIT CD34
292 hemangioma 8.9 SYP KIT ENO2 CHGA CD34
293 mixed cell type cancer 8.9 SYP KIT ENO2 CHGA CD34
294 glomangiomatosis 8.9 SYP NCAM1 KIT CHGA CD34
295 neuroendocrine carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
296 large cell neuroendocrine carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
297 small cell carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
298 merkel cell carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
299 large cell carcinoma 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
300 small cell cancer of the lung 8.8 SYP NCAM1 KRT20 KIT ENO2 CHGA
301 pheochromocytoma 8.8 SYP NCAM1 MITF KIT ENO2 CHGA
302 leber plus disease 8.7 SYP NCAM1 KRT20 KIT ENO2 CD34
303 mediastinal cancer 8.7 SYP NCAM1 KIT ENO2 CHGA CD34
304 gastrointestinal stromal tumor 8.7 SYP NCAM1 KIT ENO2 CHGA CD34
305 ewing sarcoma 8.7 SYP NCAM1 KIT ENO2 CHGA CD34
306 peripheral nervous system neoplasm 8.6 SYP NCAM1 KIT ENO2 CD34 APP

Graphical network of the top 20 diseases related to Cutaneous Ganglioneuroma:



Diseases related to Cutaneous Ganglioneuroma

Symptoms & Phenotypes for Cutaneous Ganglioneuroma

MGI Mouse Phenotypes related to Cutaneous Ganglioneuroma:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.56 APP CD34 CNP ENO2 GNS KIT
2 nervous system MP:0003631 9.28 APP CHGA CNP ENO2 GNS KIT

Drugs & Therapeutics for Cutaneous Ganglioneuroma

Search Clinical Trials , NIH Clinical Center for Cutaneous Ganglioneuroma

Genetic Tests for Cutaneous Ganglioneuroma

Anatomical Context for Cutaneous Ganglioneuroma

MalaCards organs/tissues related to Cutaneous Ganglioneuroma:

40
Skin, Adipocyte

Publications for Cutaneous Ganglioneuroma

Articles related to Cutaneous Ganglioneuroma:

(showing 16, show less)
# Title Authors PMID Year
1
Cutaneous ganglioneuroma: A case report and discussion of the literature. 61
30632184 2019
2
Primary cutaneous ganglioneuroma: anatomico-clinical study of 4 cases with focus on Merkel cells. 61
29569258 2018
3
Ganglion cell like cells, diagnostic dilemma. 61
23919032 2013
4
Primary cutaneous ganglioneuroma of the finger mimicking verruca vulgaris: a case report. 61
22719011 2013
5
Acquired primary cutaneous ganglioneuroma with adipocytic metaplasia: "An end point of melanocytic 'maturation'?" a case report and meta-analysis with comparison to a cross-sectional study of neurotized melanocytic nevi. 61
21048488 2011
6
[Facial primary cutaneous ganglioneuroma]. 61
19364589 2009
7
Cutaneous ganglioneuroma associated with overlying hyperkeratotic epidermal changes: a report of 2 cases. 61
19033938 2008
8
Cutaneous ganglioneuroma. 61
17651174 2007
9
Primary cutaneous ganglioneuroma arising within a seborrheic keratosis: a rare association. 61
15725239 2005
10
Cutaneous ganglioneuroma within a giant congenital nevus. 61
24223002 2005
11
Primary cutaneous ganglioneuroma: a report of two cases and literature review. 61
12775986 2003
12
A case of cutaneous ganglioneuroma developing within a lesion of seborrheic keratosis. 61
12081162 2002
13
Desmoplastic cutaneous ganglioneuroma. 61
9934592 1999
14
Primary congenital cutaneous ganglioneuroma. 61
8698926 1996
15
Cutaneous ganglioneuromas: a case report and review of the literature. 61
8698321 1996
16
Cutaneous ganglion cell choristoma. Report of a case. 61
1774358 1991

Variations for Cutaneous Ganglioneuroma

Expression for Cutaneous Ganglioneuroma

Search GEO for disease gene expression data for Cutaneous Ganglioneuroma.

Pathways for Cutaneous Ganglioneuroma

Pathways related to Cutaneous Ganglioneuroma according to GeneCards Suite gene sharing:

(showing 5, show less)
# Super pathways Score Top Affiliating Genes
1 11.56 NCAM1 KIT CD34
2 11.56 SYP NCAM1 ENO2 CNP APP
3 11.41 NCAM1 KIT CD34
4 11.23 NCAM1 KIT CD34
5 11 NCAM1 KIT CD34

GO Terms for Cutaneous Ganglioneuroma

Cellular components related to Cutaneous Ganglioneuroma according to GeneCards Suite gene sharing:

(showing 2, show less)
# Name GO ID Score Top Affiliating Genes
1 perinuclear region of cytoplasm GO:0048471 9.1 SYP S100A6 CNP CHGA CD34 APP
2 mast cell granule GO:0042629 8.96 KIT CHGA

Biological processes related to Cutaneous Ganglioneuroma according to GeneCards Suite gene sharing:

(showing 7, show less)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.71 MITF KIT CD34 APP
2 melanocyte differentiation GO:0030318 9.37 MITF KIT
3 axonogenesis GO:0007409 9.33 S100A6 CNP APP
4 regulation of long-term neuronal synaptic plasticity GO:0048169 9.32 SYP APP
5 mast cell degranulation GO:0043303 9.26 KIT CHGA
6 mast cell chemotaxis GO:0002551 8.96 KIT CHGA
7 mast cell cytokine production GO:0032762 8.62 KIT CHGA

Sources for Cutaneous Ganglioneuroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....